AC Immune Ltd (ACIU) Analysts See $-0.17 EPS, Telephone & Data Systems Has 1.09 Sentiment

June 5, 2017 - By Peter Erickson

Analysts expect AC Immune Ltd (NASDAQ:ACIU) to report $-0.17 EPS on June, 16. The stock increased 1.02% or $0.09 on June 2, reaching $8.9. About shares traded. AC Immune Ltd (NASDAQ:ACIU) has 0.00% since June 5, 2016 and is . It has underperformed by 16.70% the S&P500.

Telephone and Data Systems, Inc. is a diversified telecommunications company. The company has market cap of $3.22 billion. The Firm is engaged in conducting its Wireless activities through its subsidiary, United States Cellular Corporation , as well as providing its wireline services, cable services, and hosted and managed services (HMS), through its subsidiary, TDS Telecommunications Corporation (TDS Telecom).

AC Immune Ltd is a Switzerland-based firm engaged in the medical biotechnology sector. The company has market cap of $511.32 million. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson’s, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. It currently has negative earnings.

The stock increased 0.21% or $0.06 on June 2, reaching $29.1. About shares traded. Telephone & Data Systems, Inc. (TDS) has declined 0.51% since June 5, 2016 and is downtrending. It has underperformed by 17.21% the S&P500.

Eidelman Virant Capital holds 4.85% of its portfolio in Telephone & Data Systems, Inc. for 294,254 shares. Nokomis Capital L.L.C. owns 394,148 shares or 2.47% of their US portfolio. Moreover, Qv Investors Inc. has 1.77% invested in the company for 548,997 shares. The New York-based Nwi Management Lp has invested 1.75% in the stock. Sadoff Investment Management Llc, a Wisconsin-based fund reported 542,400 shares.

Since January 1, 0001, it had 0 buys, and 2 insider sales for $2.43 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.